South Korea Sets Criteria for Designating Medical Devices Requiring Long-Term Follow-Up Studies
Effective
August 1, 2025, South Korea’s amended Enforcement Rule of the Medical Device
Act will require implantable devices with frequent or potentially serious
adverse events to be formally designated for mandatory long-term follow-up. The
revision introduces a framework for the systematic collection, analysis, and
evaluation of real-world data (RWD) generated during the use of these devices,
sets out the criteria the Minister of Food and Drug Safety must apply when
making designations, and authorizes the Korea Medical Device Safety Information
Center to carry out the related tasks.
Key
Points
- Defines criteria for designating devices that require long-term
follow-up studies
- Empowers the Korea Medical Device Safety Information Center to
collect, analyze, and evaluate RWD
- Provides a legal basis for the Center to recruit physicians and
dentists for follow-up participation
- Specifies the RWD that participants must submit, including the date and details of device use and any associated adverse events
GCA Korea provides expert support for global companies navigating South Korea’s regulatory requirements. Our specialties include KC EMC, KC Safety, KC Energy Efficiency, KC Automotive Components, KCsEx (ATEX, IECEx), or MFDS (Korean Medical Devices). For tailored certification and regulatory assistance, contact GCA Korea. We’re here to streamline your market access in South Korea.
Comments
Post a Comment